Trial Profile
Pharmacokinetics of topiramate in patients with renal impairment, end-stage renal disease undergoing hemodialysis, or hepatic impairment.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Dec 2015
Price :
$35
*
At a glance
- Drugs Topiramate (Primary)
- Indications Kidney disorders; Renal impairment
- Focus Pharmacokinetics
- 07 Dec 2015 New trial record